NCT02129608View on ClinicalTrials.gov

Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
OverweightObese
Interventions
DEVICE

LLLT

The LLLT uses 6 diode laser heads - each emitting 17 mW output. Subject will receive 30 minutes of therapy in the frontal central area and 30 minutes of therapy in the back central area, once a week for 12 weeks.

DRUG

Lorcaserin

10 mg pills twice daily for 12 weeks.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02129608 - Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management | Biotech Hunter | Biotech Hunter